41st Annual Current Concepts in Emergency Care is organized by Emergencies in Medicine (EIM) and will be held from Dec 06 - 11, 2020 at Wailea Beach Resort - Marriott, Maui, Maui, Hawaii, United States of America. Accreditation: The American College of Emergency Physicians designates this live activity for a maximum of 28.5 AMA PRA Category 1 Credit(s)™. Physicians should claim only the credit commensurate with the extent of their participation in the activity. Approved by the American College of Emergency Physicians for a maximum of 28.5 hours of ACEP Category I credit Description: Pack your sunscreen and an eagerness to learn because this conference is full of experts speaking on topics like cardiovascular care, concussions, neurology, resuscitation, sports medicine, trauma, ultrasound, wilderness medicine, LLSA review, and much more. Ultrasound Course: In addition to the premium emergency medicine lectures, we offer a Multidisciplinary 5-Station Ultrasound course. Now in its 16th year, this dynamic hands-on session will provide attendees three hours to learn and perfect their skills at the following dedicated stations: • Cardiac Station (including 4-views, M-Mode, & Doppler techniques) • Abdominal Station (Gallbladder, Renal, Bladder Volume, & Female Pelvis) • Lung Station • Vascular Station (Aorta, DVT, & Central/Peripheral lines) • “Anything Goes” Station where participants can perform any scan they want under the direct auspices of an expert in Ultrasound Education. Ultrasound is indispensable for emergency physicians and the field is rapidly moving so you need to keep up with the latest techniques! Attendee feedback from this course has been very positive as it expands upon the skills you’ve already mastered and makes you more proficient at POCUS. Additional details will be posted as soon as information is available.

The 39th Annual Emergencies in Medicine Conference is organized by Emergencies in Medicine (EIM) and will be held from Mar 07 - 12, 2021 at Grand Summit Hotel, Park City, Utah, United States of America. Additional details will be posted as soon as information is available.

High-Impact Cancer Research Program is organized by Harvard Medical School (HMS). This Onsite medical conference will be held from Nov 04, 2019 - Oct 31, 2020, at Harvard Medical School, Boston, Massachusetts, United States of America. Who Should Apply: This Harvard Medical School program is open to both new and seasoned researchers including professionals in fundamental and clinical research, population health leaders of cancer-focused enterprises including scientific, policy, and financial top-flight trainees. Prospective students should hold a master’s degree in their field of study, a doctoral degree such as Ph.D., or PsyD and/or a professional degree such as an MD, MBBS, DDM, DMD, PharmD, DNP or foreign equivalent degree. What is the credit statement of the High-Impact Cancer Research Program? Accreditation: The Harvard Medical School is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to present continuing medical education for physicians. This activity meets the criteria of the Massachusetts Board of Registration in Medicine for 7.25 credits of Risk Management Study. Live Workshops: The Harvard Medical School designates this live activity for a maximum of 77.75 AMA PRA Category 1 Credits™. Physicians will be able to earn only the credit commensurate with the extent of their participation in the activity. Online Modules: The Harvard Medical School designates this enduring material for a maximum of 52.50 AMA PRA Category 1 Credits™. Physicians will be granted the credit commensurate with the extent of their participation in the activity. What is the significance of the High-Impact Cancer Research Program? Conference Overview: With so many new and promising strategies and recent developments, the opportunities to produce and enable high-impact cancer research are unprecedented. Recent advances continue to expand and reshape our views of the essential features of cancer. We are learning important new aspects of how cancers develop, how to find and diagnose cancers earlier, how to design and unleash powerful new anti-cancer therapies, and how to evaluate cancer risk and even prevent tumors from arising. These advances are delivering useful, productive changes that lead to better cancer outcomes. High-Impact Cancer Research is the acclaimed Harvard Medical School postgraduate certificate program for cancer research. It teaches the principles and skills shaping today’s most important cancer research activities. High-Impact Cancer Research faculty are distinguished leading experts who have achieved breakthroughs in fields from discovery biology to therapeutics and prevention. In this special program, world leaders in cancer research share their insights and teach this changing science. Participants learn the new fundamentals of a wide spectrum of cancer science and the skills necessary to envision, design, and lead cutting-edge cancer research projects that can contribute to these changes. What are the objectives of the High-Impact Cancer Research Program? Conference Objectives: This program is intended to help participants make high-impact contributions that manage to better cancer outcomes. Upon completion of the program, participants will be able to: • Explain the molecular and cellular basis of cancer development, detection, diagnosis, treatment, and prevention • Read about important advances within the context of clinical presentation of various human tumors and ways it is currently being used to develop the growing set of therapeutic and preventive approaches to fighting cancer • Discover about distinct cancer treatments from the individuals who developed the therapies and are testing them in ongoing clinical trials • Hone skills necessary to identify and answer key questions needed to make future contributions and to effectively communicate your ideas and conclusions • Earn critical skills to interpret and assess emerging cancer research • Envision and design cancer research projects • Improve writing skills for personal career advancement (e.g., grant applications or funding requests; the science section of a business plan designed to highlight a particular commercial opportunity; papers suitable for submission and publication) • Form an international network of colleagues and work effectively with international peers Curriculum Highlights This program allows participants to learn directly from Harvard’s leading faculty in discovery biology and clinical tumor development, and from internationally recognized leaders in the cancer research community who have achieved breakthroughs in therapeutics, risk assessment, and prevention. Peer-to-peer learning projects allow participants to learn from one another while producing publication-quality reports on important aspects of cancer research. This also allows each participant to develop a large network of international colleagues who will be resources throughout their career. Students can also customize their learning experience and skills development around their interests and career goals through two optional elective tracks (Communications or Leadership and Management) and an education track for deeper immersion into one of four areas: • Cancer -Omics • Clinically challenging cancers • Risk and prevention • Therapeutic development  • Three workshops hosted at Harvard Medical School (Boston, MA): Workshop Dates: • Workshop 1: November 4 – 8, 2019 (Boston) • Workshop 2: April 14 – 18, 2020 (Boston) • Workshop 3: October 26 – 31, 2020 (Boston).

Optimizing Patient Outcomes in Pancreatic Cancer With Al B. Benson, MD, FACP, FASCO is organized by i3 Health. Release: August 20, 2020 Expiration: August 19, 2021 Accreditation: Physicians: i3 Health designates this enduring activity for a maximum of 0.25 AMA PRA Category 1 Credits™.  Successful completion of this CME activity, which includes participation in the evaluation component, enables the participant to earn up to 0.25 Medical Knowledge MOC points in the American Board of Internal Medicine’s (ABIM) Maintenance of Certification (MOC) program. Participants will earn MOC points equivalent to the amount of CME credits claimed for the activity. It is the CME activity provider’s responsibility to submit participant completion information to ACCME for the purpose of granting ABIM MOC credit. Physician Assistants: American Academy of Physician Assistants (AAPA) accepts certificates of participation for educational activities approved for AMA PRA Category 1 Credit™ from organizations accredited by ACCME. Physician assistants may receive a maximum of 0.25 hours of Category 1 credit for completing this program. Description: With 5-year survival rates of only 37% for local disease, 12% for regional disease, and 3% for distant disease, pancreatic cancer is one of the most aggressive forms of cancer and one of the most challenging to treat. Despite the development of novel treatment approaches, therapeutic options remain limited. In this episode of Oncology Data Advisor, Al B. Benson, MD, Professor of Medicine at Northwestern University’s Feinberg School of Medicine and Associate Director for Cooperative Groups at Northwestern’s Robert H. Lurie Comprehensive Cancer Center, joins i3 Health for a discussion that covers recent developments in genomic testing and targeted therapies, supportive care measures that can optimize quality of life, and strategies that members of the cancer care team can utilize to improve the outcomes of their patients with pancreatic cancer. Learning Objectives: Upon completion of this activity, participants should be able to: • Identify the role that biomarkers can play in predicting therapeutic efficacy and developing tailored approaches to treatment • Develop effective multidisciplinary approaches that can be used to enhance pancreatic cancer treatment and supportive care https://www.i3health.com/oda-pancreatic Faculty: Al B. Benson, MD, FACP, FASCO, Professor of Medicine, Northwestern University Feinberg School of Medicine

Post Graduate Course in Homeopathy for Cranial Osteopaths is organized by Holistic Family Medicine, LLC. The symposium is held from Sep 12, 2020 - Dec 05, 2021, at Hilton Garden Inn Danbury, Danbury, Connecticut, United States of America. Dates: 10 sessions (Saturday and Sunday), 6-8 weeks apart. Saturdays 9 AM to 6 PM and Sundays 9 AM to 1 PM 2020 • September 12, 13 • November 7, 8 2021 • January 23, 24 • March 13, 14 • May 1, 2 • June 12, 13 • July 31- August 1 • September 11, 12 • October 23, 24 • December 4, 5 Accreditation: 15-month program in classical homeopathy solely for cranial osteopaths (DO & MD). AOA assigned for 120 CME credits, category 1-B. Prerequisite: Authorized DOs and MDs with former training in Osteopathy in the Cranial Field and with perceptual skills needed to work with Primary Respiration. MDs and Canadian DOs are asked to present a copy of a substantial license. It is the sole liability of the student to establish that their professional credentials permit the practice of homeopathy and that the prescribing of homeopathic medications falls within the scope of their license.  Video and audio recordings are not allowed. Course Topics: • Homeopathic Philosophy (Concepts and Methods) • Comparative Homeopathic/Osteopathic Philosophy • Homeopathic methods of history taking, symptom analysis and prescribing • Homeopathic drugs: their preparation, manufacture, pharmacology, and regulation • Homeopathic drug types • Materia Medica of commonly used homeopathic drugs • Case taking, case management for acute and chronic illness • Homeopathy in pediatrics and pregnancy • Pre and post-operative prescribing • Survey of the classical homeopathic literature • Integration of homeopathy and OMT • Integration of homeopathy and conventional therapeutics • Remedy selection using Primary Respiration (including the history of remedy testing) • Special topics • Limitations of the homeopathic method Additional details will be posted as soon as information is available.

Novel Treatment Options in Mantle Cell Lymphoma With Gilles Salles, MD, PhD is organized by i3 Health. Release: September 18, 2020 Expiration: September 17, 2021 Accreditation: Physicians: i3 Health designates this enduring activity for a maximum of 0.25 AMA PRA Category 1 Credits™.  Successful completion of this CME activity, which includes participation in the evaluation component, enables the participant to earn up to 0.25 Medical Knowledge MOC points in the American Board of Internal Medicine’s (ABIM) Maintenance of Certification (MOC) program. Participants will earn MOC points equivalent to the amount of CME credits claimed for the activity. It is the CME activity provider’s responsibility to submit participant completion information to ACCME for the purpose of granting ABIM MOC credit. Physician Assistants: American Academy of Physician Assistants (AAPA) accepts certificates of participation for educational activities approved for AMA PRA Category 1 Credit™ from organizations accredited by ACCME. Physician assistants may receive a maximum of 0.25 hours of Category 1 credit for completing this program. Description: An aggressive form of B-cell non-Hodgkin lymphoma, mantle cell lymphoma (MCL) is a challenging disease to treat, with a median overall survival of 6 to 7 years. Even in patients who achieve a complete response, recurrence and relapse are still frequent. In this episode of Oncology Data Advisor, Gilles Salles, MD, PhD, Chief of the Lymphoma Service at Memorial Sloan Kettering Cancer Center, joins i3 Health for a discussion that covers the efficacy of newly developed Bruton tyrosine kinase (BTK) inhibitor and chimeric antigen receptor (CAR) T-cell therapies, the management of adverse events associated with these treatments, updates on ongoing research, and advice for clinicians as they seek to optimize outcomes for patients with MCL. Learning Objectives: Upon completion of this activity, participants should be able to: • Assess efficacy and safety of novel BTK inhibitor therapy for MCL • Assess efficacy and safety of CAR T-cell therapy for MCL Faculty: Gilles Salles, MD, PhD Chief of the Lymphoma Service Memorial Sloan Kettering Cancer Center

Four Week Radiologic Pathology Correlation Course is organized by American Institute for Radiologic Pathology (AIRP) and will be held during Oct 19 - Nov 13, 2020 at AFI Silver, Silver Spring, Maryland, United States of America. This Course presents a comprehensive review of radiologic imaging with emphasis on the principles of radiologic-pathologic correlation. Approximately 95 percent of U.S. radiology residents attend the course at some point during their training. Additionally, a large number of radiology residents and fellows from Canada, Spain, Switzerland, the Netherlands, Asia and South America regularly attend the course. The faculty includes current and former members of the Department of Radiologic Pathology at the Armed Forces Institute of Pathology (AFIP) as well as other experts in the field. All imaging modalities are discussed and the lectures cover the radiologic presentation of a broad range of diseases and pathologic basis from all organ systems. Although the course may be beneficial at any stage of training, residents generally attend in their second, third or fourth year, as most lecturers assume that participants have at least some experience with a variety of imaging modalities. Objectives : • Apply the principles of radiologic-pathologic correlation to the interpretation of radiologic studies • Understand the clinical and treatment implications of diseases with characteristic radiologic appearances • Refine differential diagnoses in various organ systems based on specific imaging features related to their underlying pathology Additional details will be posted as soon as they are available.

American Dermatological Association (ADA) Annual Meeting 2020 is organized by American Dermatological Association (ADA) and will be held during Oct 28 - Nov 01, 2020 at Ritz Carlton Laguna Niguel, Dana Point, California, United States of America. The target audience for this medical event is Dermatologists. Additional details will be posted as soon as they are available.

Federation of Clinical Immunology Societies (FOCIS) 2020 Annual Meeting is organized by the Federation of Clinical Immunology Societies (FOCIS) and will be held from Oct 28 - 31, 2020 at San Francisco Marriott Marquis, San Francisco, California, United States of America. FOCIS remains THE meeting in translational immunology that will give you a competitive edge in your career. Stay ahead of the curve with leading clinicians and researchers delivering the latest breakthroughs across immune-mediated diseases. Focusing on molecular pathways and their implications in human disease provides a unique opportunity for innovative thinking and applying ideas from the pathologies of other diseases to uncover novel solutions to challenges in the diseases you study. Through the FOCIS Annual Meeting, researchers and clinicians share knowledge across traditional disease borders and identify commonalities between treatments and therapies that are life-changing for those affected with immune-mediated diseases. Additional details will be posted as soon as they are available.

13th Annual Neuroradiology in Clinical Practice 2020 is organized by Educational Symposia (ESI) and will be held from Oct 29 - 31, 2020 at Omni Scottsdale Resort & Spa at Montelucia, Scottsdale, Arizona, United States Of America. Target Audience: This program is designed for practicing radiologists, neurologists and neurosurgeons that interpret or rely on imaging studies for the evaluation of neurological disorders. Radiologic technologists who perform these types of procedures will also find the program beneficial. Accreditation: Physicians: Educational Symposia designates this live activity for a maximum of 18.5 AMA PRA Category 1 Credit(s)™. Physicians should claim only the credit commensurate with the extent of their participation in the activity. About The Meeting: This course is designed to address current topics in neuroimaging and the clinical management of neurological disease. Emphasis is placed on the role of imaging in pathology and trauma affecting the central nervous system. Imaging manifestation of disease, optimizing imaging techniques and the recent advanced applications of artificial intelligence (AI) and PET/MRI, traumatic brain injury and stroke imaging updates will be addressed. Educational Objectives: Attendees should, at the completion of this course, be able to: • Discuss the advances in neuroimaging applications and interpretation. • Evaluate intracranial tumors, vascular abnormalities and traumatic brain injury. • Discuss the clinical and imaging manifestations of neurodegenerative disease. • Recognize image characteristics of common neurovascular disease processes. • Utilize CTA and MRA in neuroradiology applications. • Describe the changing role of imaging in the management of spine disease. • Explain the clinical impact of artificial intelligence in neuroradiology. Note: This Course is also available as Webcast. Save the Date! More Information Coming Soon For the most updated conference information please visit the webpage: https://www.edusymp.com/product/details/1310 Additional details will be posted as soon as information is available.